191420 — Tego Science Balance Sheet
0.000.00%
- KR₩128bn
- KR₩91bn
- KR₩7bn
Annual balance sheet for Tego Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 21,427 | 21,311 | 22,308 | 20,915 | 27,339 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,946 | 4,237 | 3,535 | 3,353 | 2,970 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26,518 | 26,533 | 27,452 | 28,231 | 32,134 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17,795 | 17,260 | 16,774 | 16,485 | 16,084 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 50,380 | 51,004 | 51,363 | 48,910 | 52,515 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,404 | 2,484 | 2,607 | 2,181 | 2,285 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,491 | 2,530 | 2,766 | 2,447 | 2,656 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 48,889 | 48,474 | 48,596 | 46,463 | 49,860 |
| Total Liabilities & Shareholders' Equity | 50,380 | 51,004 | 51,363 | 48,910 | 52,515 |
| Total Common Shares Outstanding |